DAVS
The Dutch Annual Virology Symposium (DAVS) provides a platform for young and established virologists to present their research. Traditionally, the symposium takes place around the first week of March in Amsterdam.
DAVS 2019
In 2019, the DAVS will be held on Friday March 8 and, as were the previous editions, will be situated in the “Openbare Bibliotheek Amsterdam” (OBA).
Call for abstracts
You are kindly invited to submit your abstract for oral presentations by email to virology[at]uu.nl. Please include institute, title, and authors (indicate presenter by underlining) in your abstract (300 words max.). Deadline for submission is January 28, 2019. For more information, please refer to the call for abstracts PDF.
Registration
You can register for this meeting on the KNAW website. Participation is free of charge, but registration is required.
Location
Openbare Bibliotheek van Amsterdam
Theaterzaal OBA, zevende etage
Oosterdokskade 143
1011 DL Amsterdam
Program
See below for a list of the presentations, a detailed time schedule can be found as a PDF here.
Inhibition of Chikungunya virus replication by targeting host S-adenosyl-homocysteine hydrolase and viral nonstructural protein 1
Martijn van Hemert | LUMC - Leiden
Identification of a novel inhibitor of alphavirus entry
Finny Varghese | Radboudumc - Nijmegen
Viral factors important for the neurotropism of influenza A viruses
Jurre Siegers | Erasmus MC - Rotterdam
The Epstein-Barr virus BART18 microRNA directly targets host genes to affect autophagy in infected cells
Hendrik de Buhr | UMCU - Utrecht
The transcriptional complexity of varicella-zoster virus unraveled by direct RNA nanopore sequencing
Shirley Braspenning | Erasmus MC - Rotterdam
Structure and immunogenicity of a stabilized HIV-1 envelope trimer based on a group M consensus sequence
Kwinten Sliepen | AMC-UvA - Amsterdam
Bispecific single-domain antibody-based complexes protect against bunyavirus infections
Paul Wichgers Schreur | WUR - Wageningen
Engineering yellow fever virus 17D–based RNA replicons into an innovative DNA-launched vaccine vector platform for emerging viruses such as MERS-CoV
Marjolein Kikkert | LUMC – Leiden
Betacoronavirus S and HE proteins are in functional balance; evidence for convergent evolution of betacorona- and influenzaviruses
Yifei Lang | UU - Utrecht
Human vaginal and skin dendritic cell subsets control ZIKA virus infection
Julia Eder | AMC-UvA - Amsterdam
Zika virus infection perturbs osteoblast function
Noreen Mumtaz | Erasmus MC - Rotterdam
Subgenomic flavivirus RNA binds the antiviral mosquito DEAD-box helicase ME31B and determines Zika virus transmission by Aedes aegypti
Giel Goertz | WUR – Wageningen
Protective human monoclonal antibodies targeting different stages of MERS coronavirus entry
Berend Jan Bosch | UU - Utrecht
Beijerinck Premium Lectures
Illuminating influenza A virus receptor interactions
Robert de Vries | Department of Chemical Biology and Drug Discovery, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht
Measles: not an innocent childhood disease
Rory de Vries | Department of Viroscience, Erasmus MC, Rotterdam
Beijerinck Prize Lecture
The Flavivirus NS1 protein: Unraveling mechanisms of pathogenesis of dengue, Zika, and beyond
Eva Harris | Division of Infectious Diseases and Vaccinology, School of Public Health, University of California, Berkeley, Berkeley, California, United States